Warfarin interactions with antibiotics in the ambulatory care setting

JAMA Internal Medicine

Volumn 174, Issue 3, 2014, Pages 409-416

  Clark, Nathan P ^a,b   Delate, Thomas ^a,b   Riggs, Catherine S ^a   Witt, Daniel M ^a,b   Hylek, Elaine M ^c   Garcia, David A ^d   Ageno, Walter ^e   Dentali, Francesco ^e   Crowther, Mark A ^f  

^a Department of Clinical Pharmacy Kaiser Permanente Colorado ^*  (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFUROXIME AXETIL; CIPROFLOXACIN; CLINDAMYCIN; CODEINE; COTRIMOXAZOLE; DOXYCYCLINE; GUAIFENESIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; NITROFURANTOIN; PENICILLIN DERIVATIVE; TRIMETHOPRIM; WARFARIN;

AGED; AMBULATORY CARE; ANTIBIOTIC THERAPY; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; INTERNATIONAL NORMALIZED RATIO; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RETROSPECTIVE STUDY; UPPER RESPIRATORY TRACT INFECTION; VENOUS THROMBOEMBOLISM;

AGED; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; DRUG INTERACTIONS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; WARFARIN;

EID: 84897713557     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.13957     Document Type: Article

References (22)

1. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095-1106. (Pubitemid 40720733)
2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6)(suppl): 160S-198S. (Pubitemid 351892967)
3. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121(9):676-683.
4. Fihn SD, McDonell M, Martin D, et al Warfarin Optimized Outpatient Follow-up Study Group. Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med. 1993;118(7):511-520. (Pubitemid 23085793)
5. Witt DM, Delate T, Clark NP, et al; Warfarin Associated Research Projects and Other EnDeavors (WARPED) Consortium. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood. 2009;114(5):952-956.
6. Wallentin L, Yusuf S, Ezekowitz MD, et al RE-LY Investigators. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet. 2010;376(9745):975-983.
7. Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2)(suppl):e44S-e88S. doi:10.1378/chest.11-2292.
8. Anthony M, Romero K, Malone DC, Hines LE, Higgins L, Woosley RL. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. Clin Pharmacol Ther. 2009;86(4):425-429.
9. Schelleman H, Bilker WB, Brensinger CM, Han X, Kimmel SE, Hennessy S. Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. Clin Pharmacol Ther. 2008;84(5):581-588.
10. Glasheen JJ, Fugit RV, Prochazka AV. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med. 2005;20(7):653-656. (Pubitemid 41026254)
11. Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest. 2005;127(5):1515-1522. (Pubitemid 46218774)
12. Micromedex Healthcare Series, Version 5.1. Greenwood Village, CO: Thomson Healthcare. http://www.micromedexsolutions.com/micromedex2/librarian. Accessed July 17, 2013.
13. Hansten PD, Horn JR. Drug Interactions: Analysis and Management: A Clinical Perspective and Analysis of Current Developments. St Louis, MO: Facts & Comparisons; 2006.
14. Mlinaric-Galinovic G, Falsey AR, Walsh EE. Respiratory syncytial virus infection in the elderly. Eur J Clin Microbiol Infect Dis. 1996;15(10):777-781. (Pubitemid 26386118)
15. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA. 1998;279(9):657-662. (Pubitemid 28138733)
16. Mahé I, Bertrand N, Drouet L, et al. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study. Haematologica. 2006;91(12):1621-1627. (Pubitemid 46032959)
17. Hirsh J, Fuster V, Ansell J, Halperin JL; American Heart Association; American College of Cardiology Foundation. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation. 2003;107(12):1692-1711. (Pubitemid 36397341)
18. Richards RK. Influence of fever upon the action of 3,3methylene bis-(4-hydroxycoumarin) (dicumarol). Science. 1943;97(2518):313-316.
19. Dowd MB, Vavra KA, Witt DM, Delate T, Martinez K. Empiric warfarin dose adjustment with prednisone therapy: a randomized, controlled trial. J Thromb Thrombolysis. 2011;31(4):472-477.
20. Ahmed A, Stephens JC, Kaus CA, Fay WP. Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin. J Thromb Thrombolysis. 2008;26(1):44-48.
21. Crowther MA, Ageno W, Garcia D, et al. Oral vitamin K vs placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009;150(5):293-300.
22. Crowther MA, Garcia D, Ageno W, et al. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Thromb Haemost. 2010;104(1):118-121.